Literature DB >> 1890016

Complete nucleotide sequence of a genomic clone encoding HLA-B35 isolated from a Caucasian individual of Hispanic origin. Identification of a new variant of HLA-B35.

L P Chertkoff1, M Herrera, L Fainboim, M L Satz.   

Abstract

The primary structure of an HLA class I genomic clone isolated from a homozygous HLA-B35 Caucasian individual of hispanic origin was determined. The nucleotide sequence of exons 1, 2, 4, 5, 6, and 7 is identical to that of the HLA-B35 allele of Oriental origin reported previously. Exon 3 differs in only three nucleotides present in a stretch of 23 bp. These changes introduce three amino acid substitutions in residues 109 (Leu----Phe), 114 (Asp----Asn), and 116 (Ser----Tyr), two of which (114 and 116) are located in one of the beta sheets at the bottom of the peptide binding site. The nature of these replacements in this HLA-B35 variant is likely to affect peptide binding and recognition by T lymphocytes. Introns 1, 2, 3, 4, 5, and 6 from this genomic clone are identical to those present in HLA-Bw58, further confirming the evolutionary origin of HLA-B35.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1890016     DOI: 10.1016/0198-8859(91)90020-a

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Sequence polymorphism in the HLA-B promoter region.

Authors:  Z Yao; A Volgger; S Scholz; E D Albert
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  A new HLA-B15 allele (B*1522) found in Bari-Motilones Amerindians in Venezuela: comparison of its intron 2 sequence with those of B*1501 and B*3504.

Authors:  J Martinez-Laso; Z Layrisse; E Gomez-Casado; F Montoya; Y Guédez; E Dominguez; P Varela; A Arnaiz-Villena
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

Authors:  L T Peltenburg; P I Schrier
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

Authors:  L T Peltenburg; R Dee; P I Schrier
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

6.  Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.

Authors:  Y Beck; L Satz; Y Takamiya; S Nakayama; L Ling; Y Ishikawa; T Nagao; H Uchida; K Tokunaga; C Müller
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.